To the Editor:
We read with great interest the recent article by Fischer et al. (1) on uracil-DNA glycosylase and its expression modulated by fluorodeoxyuridine (FdUrd). As a particular observation, the authors provide evidence that FdUrd-induced uracil-DNA glycosylase degradation occurred in late G 1 -early S transition instead of late S-G 2 -M phase as was observed previously in normally cycling cells (2) . This was shown by fluorescence-activated cell sorting (FACS) analysis using propidium iodide staining, which is a most common assay of cell cycle analysis.
In our opinion, FACS analysis of cell cycling after propidium iodide staining alone contains a major drawback in that early and late S-phases are superposed by the G 1 and G 2 -M phases. Under normal cycling circumstances, only a minor fraction of S-phase cells might be hidden by the G 1 and G 2 -M peaks and can be quite reliably extrapolated by conventional cell cycle analysis software. However, when using cell cycle-modifying chemicals such as FdUrd, simple propidium iodide staining might be less adequate for such analyses.
We and others have observed repeatedly that FdUrd was able to induce a cell cycling block early in S phase (3) (4) (5) . This was shown by double staining FACS analysis using iododeoxyuridine (IdUrd) and anti-IdUrd fluorescence staining combined with DNA staining by propidium iodide. In this analysis, all S-phase cells are stained based on incorporation of IdUrd into DNA and appear in a window different from that of G 1 and G 2 -M phases, the latter being colored by propidium iodide staining alone. We thus showed in three different glioblastoma cell lines and an ovarian cancer line that cells accumulated in early S phase after FdUrd treatment (3, 4) . Similar results have been reported for HT29 cells (5) . The fact that these cells were ready to incorporate IdUrd indicates to us that they had already passed the primary ''restriction'' G 1 checkpoint.
Concerning the article by Fischer et al. (1), we therefore think that the cell cycle analysis shown in Fig. 2 is not reliable and possibly resulted in a major overestimation of G 1 phase and a correlated underestimation of the S-phase cells. This led to the particular difficulty of defining the phase of uracil-DNA glycosylase degradation, which, according to their discussion, remains hypothetically in late G 1 -early S phase, possibly associated with a checkpoint mechanism. We would postulate that with a more adequate cell cycle analysis, the cell cycle arrest induced by FdUrd could have been better defined, would possibly be attributed to the early S phase, and would therefore better fit their previous observation of uracil-DNA glycosylase expression. In our opinion, their results observed after aphidicolin G 1 -S boundary block (1) 
